MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, BNBX made $565,394 in revenue. -$18,626,390 in net income. Net profit margin of -3294.41%.

Income Overview

Revenue
$565,394
Net Income
-$18,626,390
Net Profit Margin
-3294.41%
EPS
-$2.08
Unit: Dollar
Revenue Breakdown
    • Therapeutic Dna Production
    • Dna Tagging And Security Product...
    • Dna Tagging And Security Product...
    • Therapeutic Dna Production
Revenue Breakdown
    • Large Scale Dna Production
    • Supply Chain
    • Research And Development Service...
Revenue Breakdown
    • Therapeutic Dna Production
    • Dna Tagging And Security Product...

Unit: Dollar
Income Statement
2025-12-31
2025-09-30
Total revenues
565,394 534,233.75
Cost of product revenues
250,037 324,507
Gross profit
315,357 209,726.75
Selling, general and administrative
13,348,510 2,717,147.5
Loss from fair value measurement of digital assets
-1,732,557 -
Loss from fair value measurement of investment in digital asset trust
-3,484,009 -
Research and development
458,562 1,504,228
Total operating expenses
19,023,638 4,221,375.5
Loss from operations
-18,708,281 -4,011,648.75
Interest income
9,143 48,228.75
Unrealized gain on change in fair value of warrants classified as a liability
-370 -79,907.5
Other income (expense), net
92,586 -26,645
Loss before provision for income taxes
-18,606,182 -3,910,157.5
Income tax provision benefit
--171,028.75
Net loss from continuing operations
-18,606,182 -3,739,128.75
Clinical laboratory service revenues
-143,232
Cost of clinical laboratory service revenues
-197,613.75
Gross profit
--54,381.75
Selling, general and administrative
-53,776.25
Interest (income)
-825.25
Other expense, net
-9,150
Net loss from discontinued operations
--98,182.75
Net loss from discontinued operations, net of tax
--98,182.75
Net loss
-18,606,182 -3,837,311.5
Less net loss attributable to noncontrolling interest
-12,619 -47,130.5
Net loss attributable to bnb plus corp
-18,593,563 -3,790,181
Deemed dividend related to warrant modifications
32,827 13,581,724
Net loss attributable to common stockholders
-18,626,390 -17,371,905
Earnings per share, basic
-2.08 -33.558
Earnings per share, diluted
-2.08 -33.558
Weighted average number of shares outstanding, basic
8,942,937 129,417.75
Weighted average number of shares outstanding, diluted
8,942,937 129,417.75
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$18,626,390 Net lossattributable to bnb plus corp-$18,593,563 Deemed dividendrelated to warrant...$32,827 Less net lossattributable to...-$12,619 Net loss-$18,606,182 Therapeutic Dna Production$450,548 Dna Tagging AndSecurity Products$104,545 Dna Tagging AndSecurity Products$9,038 Therapeutic Dna Production$1,263 Net loss fromcontinuing operations-$18,606,182 Product$555,093 Service$10,301 Loss beforeprovision for income taxes-$18,606,182 Other income(expense), net$92,586 Interest income$9,143 Unrealized gain on change infair value of...-$370 Total revenues$565,394 Loss from operations-$18,708,281 Gross profit$315,357 Cost of productrevenues$250,037 Total operatingexpenses$19,023,638 Selling, general andadministrative$13,348,510 Loss from fair valuemeasurement of investment in...-$3,484,009 Loss from fair valuemeasurement of digital...-$1,732,557 Research and development$458,562

BNB PLUS CORP. (BNBX)

BNB PLUS CORP. (BNBX)